<DOC>
	<DOCNO>NCT01684943</DOCNO>
	<brief_summary>The investigator research study compare pharmacokinetics ( rate absorption ) insulin lispro ( Humalog ) , insulin aspart ( Novolog ) , insulin glulisine ( Apidra ) within individual subject . Additionally , investigator perform preliminary feasibility evaluation minimally invasive continuous insulin monitoring ( CIM ) device use derive PK parameter human subject .</brief_summary>
	<brief_title>Selecting Insulin Analogs Closed-Loop Control Using Multiplex Pharmacokinetic Profiling</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 12 year old clinical type 1 diabetes least five year Diabetes manage use insulin infusion pump rapid veryrapidacting insulin include insulin aspart ( NovoLog ) , insulin lispro ( Humalog ) , insulin glulisine ( Apidra ) . Ability consume sufficient amount carbohydrates 23 hour cover 9 unit rapid acting insulin Unable provide inform consent Unable comply study procedure Inadequate venous access determine study nurse physician time screen . Pregnancy History gastric banding , gastric bypass , gastrointestinal condition may prevent subject consume normal sized meal Hemoglobin &lt; 13.5 men , &lt; 12 woman</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>